Commercial validation
EV Biotech’s unique technology platform offers the possibility to produce green products such as proteins, food ingredients, flavours, fragrances, cosmetic ingredients, materials, bio-pesticides and much more. Their strategy gives the unique advantage of getting them on the market faster and at a competitive price.
Within the past few years, EV Biotech’s platform has been commercially tested. There have been seven different client projects concerning production methods for alternative proteins, small molecules and bioplastics . In addition to these projects, EV Biotech has developed an in-house bioplastic-producing microbial chassis that is able to produce bioplastics efficiently, accumulating up to 80% of its biomass. They plan to pilot this microbial chassis this year, and aim for an entry to market within 3 years. This is a stark 70% time-to-market improvement compared to traditional trial-and-error strain design approaches.
Using modelling to guide our lab experiments saves at least 60% of the time and cost
Agnieszka Wegrzyn, CTSO